On Tuesday shares of Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) closed at $6.35. Company’s sales growth for last 5 years was -1.50% and EPS growth for next 5 years is recorded as 25.00%. Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) had its price objective cut by Northland Securities from $11.00 to $9.00 in a research report released on Friday morning. Northland Securities currently has an outperform rating on the stock.
United States Steel Corp. (NYSE:X) in last trading activity moved up 4.18% to close at $25.90. Company weekly performance is 5.07% while its quarterly performance stands at 11.02%. United States Steel Corp. (NYSE:X) is -44.17% away from its 52 week high. United States Steel Corp. (NYSE:X) announced that interested stockholders, investors and others may listen to the company’s first quarter 2015 conference call with securities analysts on Wednesday, April 29, 2015, at 8:30 a.m. EDT.
On last trading day Trinity Biotech plc (NASDAQ:TRIB) moved up 0.28% to close at $17.79. Its volatility for the week is 2.14% while volatility for the month is 3.16%. TRIB’s sales growth for past 5 years was -3.60% and its EPS growth for past 5 years was 5.40%. Trinity Biotech plc (NASDAQ:TRIB) monthly performance is -4.41%. Trinity Biotech plc (NASDAQ:TRIB) announced that Trinity Biotech Investment Limited, its wholly-owned subsidiary (the “Issuer”), closed its offering of $115 million aggregate principal amount of Exchangeable Senior Notes due 2045 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).
On last trading day Inovio Pharmaceuticals, Inc. (NASDAQ:INO) moved up 6.07% to close at $10.48. Its volatility for the week is 7.21% while volatility for the month is 7.77%. INO’s sales growth for past 5 years was 2.90% and its EPS growth for past 5 years was 14.20%. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) monthly performance is 48.86%. On 8 April, Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced that the company has been selected to receive a grant from the Defense Advanced Research Projects Agency (DARPA) to lead a collaborative team to develop multiple treatment and prevention approaches against Ebola.
Juniper Networks, Inc. (NYSE:JNPR) shares moved up 1.65% in last trading session and ended the day at $23.99. JNPR Gross Margin is 61.80% and its return on assets is -3.50%. Juniper Networks, Inc. (NYSE:JNPR) quarterly performance is 7.29%. Juniper Networks, Inc. (NYSE:JNPR) confirmed it will release preliminary financial results for the quarter ended March 31, 2015, on April 23, 2015 after the close of the market and will host a conference call at 2:00 p.m. PDT (Pacific Daylight Time), to be broadcast live over the Internet.